High risk groups problems led to delays in HIV Prevention Drug ResearchA ‘combination of scientific caution and the fiery politics AIDS ‘led to a delay in the research on HIV transmission to avoid with antiretroviral drugs, although the effectiveness of the practice has early 1990s early 1990s, the New York Times reports.
While researchers found that a drug in Truvada could protect monkey with monkeys HIV in 1995 , and reached a similar finding among people lasted until 2010. Robert Grant, 2001 and 2002. The Gladstone Institute and lead author of study prep Truvada, that the distance to Truvada drug components is not related to approved 2001 and 2002. Other antiretroviral drugs such as AZT and nevirapine, have to be taken as unsafe for HIV-negative people. Grant said: ‘We work began to prep the minute the right drugs became available. ‘. Continue reading “Although the effectiveness of the practice has early 1990s early 1990s.”